Totally implanted venous access-associated adverse events in oncology: Results from a prospective 1-year surveillance programme.

We report accurate estimations of TIVA-AE incidences in one of the largest populations among previously published studies. As in previous studies, metastatic cancers and hematologic malignancies tended to be associated with a higher risk of infectious TIVA-AE. Further studies are warranted to confirm the effect of digestive cancers.
PMID: 30322697 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - October 12, 2018 Category: Cancer & Oncology Authors: Vermeulin T, Lucas M, Marini H, Di Fiore F, Loeb A, Lottin M, Daubert H, Gray C, Guisier F, Sefrioui D, Michel P, de Mil R, Czernichow P, Merle V Tags: Bull Cancer Source Type: research